| Gordon Carl L |
Non-Executive Director |
MBX Biosciences, Inc. (MBX)
|
2024-09-16 |
$16.00 |
0.0% |
750,000
|
$12,000,000 |
| Gordon Carl L |
Non-Executive Director |
ArriVent Biopharma, Inc. (AVBP)
|
2024-01-30 |
$18.00 |
47.8% |
444,444
|
$7,999,992 |
| Gordon Carl L |
Non-Executive Director |
Adicet Bio, Inc. (ACET)
|
2024-01-25 |
$2.40 |
-40.0% |
3,125,000
|
$7,500,000 |
| Gordon Carl L |
Non-Executive Director |
Theseus Pharmaceuticals, Inc. (THRX)
|
2023-07-17 |
$3.05 |
33.1% |
479,932
|
$1,463,793 |
| Gordon Carl L |
Non-Executive Director |
Adicet Bio, Inc. (ACET)
|
2023-06-27 |
$2.09 |
-31.1% |
875,000
|
$1,828,750 |
| Gordon Carl L |
Non-Executive Director |
Kinnate Biopharma Inc. (KNTE)
|
2023-05-05 |
$2.80 |
-5.3% |
1,460,932
|
$4,086,235 |
| Gordon Carl L |
Non-Executive Director |
Kinnate Biopharma Inc. (KNTE)
|
2023-05-02 |
$2.61 |
1.4% |
1,405,168
|
$3,673,901 |
| Gordon Carl L |
Non-Executive Director |
Terns Pharmaceuticals, Inc. (TERN)
|
2022-12-23 |
$7.25 |
2.9% |
137,931
|
$1,000,000 |
| Gordon Carl L |
Non-Executive Director |
Compass Therapeutics, Inc. (CMPX)
|
2022-11-08 |
$3.21 |
-53.6% |
402,000
|
$1,290,420 |
| Gordon Carl L |
Non-Executive Director |
Theseus Pharmaceuticals, Inc. (THRX)
|
2022-11-07 |
$5.21 |
-22.1% |
192,000
|
$1,000,320 |
| Gordon Carl L |
Non-Executive Director |
Terns Pharmaceuticals, Inc. (TERN)
|
2022-08-16 |
$2.42 |
208.3% |
3,690,000
|
$8,929,800 |
| Gordon Carl L |
Non-Executive Director |
Compass Therapeutics, Inc. (CMPX)
|
2022-05-13 |
$2.18 |
-31.8% |
192,516
|
$420,482 |
| Gordon Carl L |
Non-Executive Director |
Compass Therapeutics, Inc. (CMPX)
|
2022-05-10 |
$1.57 |
-5.3% |
125,359
|
$197,252 |
| Gordon Carl L |
Non-Executive Director |
Kinnate Biopharma Inc. (KNTE)
|
2022-02-15 |
$10.17 |
-73.9% |
195,700
|
$1,989,446 |
| Gordon Carl L |
Non-Executive Director |
Theseus Pharmaceuticals, Inc. (THRX)
|
2022-01-21 |
$9.97 |
-59.3% |
158,417
|
$1,578,717 |
| Gordon Carl L |
Non-Executive Director |
Theseus Pharmaceuticals, Inc. (THRX)
|
2022-01-13 |
$9.90 |
-59.0% |
44,717
|
$442,750 |
| Gordon Carl L |
Non-Executive Director |
Compass Therapeutics, Inc. (CMPX)
|
2021-11-04 |
$3.50 |
-57.4% |
5,357,143
|
$18,750,000 |
| Gordon Carl L |
Non-Executive Director |
Theseus Pharmaceuticals, Inc. (THRX)
|
2021-10-12 |
$16.00 |
-74.6% |
625,000
|
$10,000,000 |
| Gordon Carl L |
Non-Executive Director |
Terns Pharmaceuticals, Inc. (TERN)
|
2021-02-09 |
$17.00 |
-56.1% |
475,000
|
$8,075,000 |
| Gordon Carl L |
Non-Executive Director |
Kinnate Biopharma Inc. (KNTE)
|
2020-12-02 |
$20.00 |
-86.8% |
750,000
|
$15,000,000 |
| Gordon Carl L |
Non-Executive Director |
Oric Pharmaceuticals, Inc. (ORIC)
|
2020-04-24 |
$16.00 |
-40.8% |
281,250
|
$4,500,000 |
| Gordon Carl L |
Non-Executive Director |
Keros Therapeutics, Inc. (KROS)
|
2020-04-13 |
$16.00 |
235.5% |
375,200
|
$6,003,200 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-6.8% |
$-7,994,701 |
$117,730,058 |